DiBiase Mary

Track

Insider profile

Performance

Overall performance
2.3
Performance over holding periods
2.3
30 days 90 days 120 days
Average return -22% 8.2% 15.1%
Success rate 29% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
DiBiase Mary's trades of X4 Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
477.98
Quantity 67,335 +25.8%
Value US$2,715,281
Transaction date
Proposed sale
Price
72.39
Quantity 3,035
Value US$4,837,701
Transaction date
Proposed sale
Price
0.64
Quantity 67,695
Value US$43,095
Transaction date
Proposed sale
Price
0.65
Quantity 2,642
Value US$1,728
Transaction date
Proposed sale
Price
0.90
Quantity 15,409
Value US$13,868
Transaction date
Proposed sale
Price
0.97
Quantity 3,683
Value US$3,573
Transaction date
Proposed sale
Price
0.79
Quantity 67,695
Value US$53,553
Transaction date
Proposed sale
Price
1.24
Quantity 2,642
Value US$3,276
Transaction date
Proposed sale
Price
1.93
Quantity 857
Value US$1,652
Transaction date
Proposed sale
Price
2.23
Quantity 857
Value US$1,911
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-01-27 2025-01-24
PlS Planned sale
67,335 +25.8%
477.98
US$2,715,281 		67,335 +25.8% 477.98 US$2,715,281
2025-01-24 2025-01-24
PrS Proposed sale
3,035
72.39
US$4,837,701 		3,035 72.39 US$4,837,701
2024-10-08 2024-10-07
PlS Planned sale
15,318 -18.2%
33.09
US$4,555,280 		15,318 -18.2% 33.09 US$4,555,280
2024-10-07 2024-10-07
PrS Proposed sale
67,695
0.64
US$43,095 		67,695 0.64 US$43,095
2024-09-11 2024-09-09
S Sale
2,642 -0.9%
0.66
US$1,738 		2,642 -0.9% 0.66 US$1,738
2024-09-09 2024-09-09
PrS Proposed sale
2,642
0.65
US$1,728 		2,642 0.65 US$1,728
2024-03-11 2024-03-11
PrS Proposed sale
15,409
0.90
US$13,868 		15,409 0.90 US$13,868
2024-03-11 2024-03-11
S Sale
15,409 -5.0%
0.88
US$13,591 		15,409 -5.0% 0.88 US$13,591
2024-02-12 2024-02-12
PrS Proposed sale
3,683
0.97
US$3,573 		3,683 0.97 US$3,573
2024-02-12 2024-02-12
S Sale
3,683 -1.2%
1.01
US$3,709 		3,683 -1.2% 1.01 US$3,709
2023-11-03 2023-11-01
PlS Planned sale
67,695 -17.9%
0.73
US$49,417 		67,695 -17.9% 0.73 US$49,417
2023-11-01 2023-11-01
PrS Proposed sale
67,695
0.79
US$53,553 		67,695 0.79 US$53,553
2023-09-12 2023-09-08
PlS Planned sale
2,642 -1.8%
1.25
US$3,300 		2,642 -1.8% 1.25 US$3,300
2023-09-08 2023-09-08
PrS Proposed sale
2,642
1.24
US$3,276 		2,642 1.24 US$3,276
2023-07-05 2023-06-30
PlS Planned sale
464 -0.3%
1.89
US$877 		464 -0.3% 1.89 US$877
2023-06-26 2023-06-23
PlS Planned sale
857 -0.6%
1.93
US$1,654 		857 -0.6% 1.93 US$1,654
2023-06-23 2023-06-23
PrS Proposed sale
857
1.93
US$1,652 		857 1.93 US$1,652
2023-06-16 2023-06-15
PlS Planned sale
857 -0.6%
2.23
US$1,911 		857 -0.6% 2.23 US$1,911
2023-06-15 2023-06-15
PrS Proposed sale
857
2.23
US$1,911 		857 2.23 US$1,911
2023-03-13 2023-03-10
PlS Planned sale
18,192 -10.6%
0.84
US$15,281 		18,192 -10.6% 0.84 US$15,281
2023-02-15 2023-02-13
PlS Planned sale
4,348 -2.5%
0.93
US$4,044 		4,348 -2.5% 0.93 US$4,044
2022-08-19 2022-08-17
PlS Planned sale
1,713
0.00
US$0 		1,713 0.00 US$0
2022-07-01 2022-06-30
PlS Planned sale
1,578
0.00
US$0 		1,578 0.00 US$0
2022-06-27 2022-06-24
PlS Planned sale
856
0.00
US$0 		856 0.00 US$0
2022-06-17 2022-06-16
PlS Planned sale
856
0.00
US$0 		856 0.00 US$0
2022-02-14 2022-02-11
PlS Planned sale
12,545
0.00
US$0 		12,545 0.00 US$0